October 7, 2017, 2:00 -5:00 PM
Holiday Inn 3405 W Algonquin Rd, Rolling Meadows, IL 60008
Chaired by
- Dr. Ying Liu, Associate Professor, University of Illinois at Chicago
Participating Investors
- Gavin Xia, Ph.D, Principal, Lilly Asia Ventures
- Haipeng Cheng, Ph.D, Head, North America, Sangel Venture Capital
- Daniel Wang, Member, Hyde Park Angels
- Weiqiang Huang, Ph.D, Managing Partner, HeYongWeiMing Venture
- To Be Confirmed
Agenda
October 7, 2017
2:00 – 2:30 PM
“Strategy, Value Proposition, and Investment Guidelines”
Gavin Xia, Ph.D, Principal, Lilly Asia Ventures
Haipeng Cheng, Ph.D, Head, North America, Sangel Venture Capital
Daniel Wang, Member, Hyde Park Angels
Weiqiang Huang, Ph.D, Managing Partner, HeYongWeiMing Venture
Others
2:30 – 5:00 PM
Roadshow Presentations
2:30 – 2:50 PM
“Next Generation Therapeutics to Improve Outcomes for Patients with Chronic Kidney Disease and Osteoporosis”
Ruth Wu-Wong, Ph.D., CSO and Founder, Vidasyn Inc.
2:50 – 3:10 PM
“Breakthrough Therapies for Alzheimer’s and Parkinson’s Disease”
Russell Dahl, Ph.D., CEO and Founder, Neurodon LLC
3:10 – 3:30 PM
“HuTARG Technology for Production of Human Antibody”
Kevin Zhang, Ph.D., CSO, Innovative Targeting Solutions, Inc., Canada
3:30 – 3:50 PM
“TBD”
Jim Lu, MD, President, GoPath Laboratories, Inc.
3:50 – 4:10 PM
“TBD”
Michael T. Flavin, Ph.D., CEO, Shamrock Structures LLC
4:10 – 4:30 PM
“Novel Artesunate Formulation and Clinical Applications”
Mitch Zhao, Ph.D., CEO, Glycopep Corp.
4:30 – 4:50 PM
“Core CLIA IVD Reagent CDMO and Value Added Services”
Yingqing Huang, Ph.D., President and Founder, Innokare LLC
To register, send an email to guidong.zhu@yypharm.org
Address & Map
